Top Qs
Timeline
Chat
Perspective
Ramatroban
Chemical compound From Wikipedia, the free encyclopedia
Remove ads
Ramatroban (INN; also known as BAY u3405)[1] is a thromboxane receptor antagonist.[2] It is also a DP2 receptor antagonist.[3]
Ramatroban is indicated for the treatment of coronary artery disease.[4] It has also been used for the treatment of asthma.[5]
It has been suggested that ramatroban, by modulating DP2 receptor, can reverse viremia-associated proinflammatory and prothrombotic processes which are similar to those induced by SARS-Cov-2.[citation needed] Hence, ramatroban, that has been used for the treatment of allergic rhinitis in Japan for the past two decades with a well established safety profile, merits investigation as a novel immunotherapy for the treatment of COVID-19 disease, although no clinical trial has yet been conducted.[6]
Ramatroban was developed by the German pharmaceutical company Bayer AG and is co-marketed in Japan by Bayer Yakuhin then marketed by Kyorin Pharmaceutical and Nippon Shinyaku Co., Ltd. under the trade name Baynas.
It is a tetrahydrocarbazolamine derivative and cyclized tryptamine.
Remove ads
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads